Results 121 to 130 of about 3,957 (191)

Glutathione Peroxidases 1 and 3 Immunoscores in Clear Cell Renal Cell Carcinoma: New Insights from a Case-Series Study. [PDF]

Oncol Res
Vageli DP, Doukas PG, Papageorgiou N, Markou CA, Zacharouli K, Ioannou M.   +5 more
europepmc   +1 more source

Th1-2 immune balance revisited: refining prognostic immune signatures in colorectal cancer. [PDF]

J Gastrointest Oncol
Meier C, Brieger A.
europepmc   +1 more source

Immunohistochemical Study of the Tumor Immune Microenvironment in Laryngeal Squamous Cell Carcinoma and Its Prognostic Implications. [PDF]

Diagnostics (Basel)
Sirbu MI, Zara F, Closca RM, Rakitovan M, Armega-Anghelescu A, Cindrea AC, Mederle OA, Labadi MM, Balica NC.   +8 more
europepmc   +1 more source

Prognostic significance of integrating pretreatment biopsy-derived Immunoscore and Pan-Immune-Inflammation value in locally advanced rectal cancer after neoadjuvant chemoradiotherapy. [PDF]

Clin Transl Radiat Oncol
Kim MJ, Lee HW, Shin DI, Jeong WK, Baek SK, Bae SU.   +5 more
europepmc   +1 more source

Immunoscore and beyond: evolution and clinical integration of immune contexture-based biomarkers across solid tumours. [PDF]

Front Immunol
Orenes-Piñero E, Ros-Martínez S, Alonso-Romero JL, Ortega-García JA.   +3 more
europepmc   +1 more source

TCGA-Informed Spatial Profiling Reveals Peripheral CD147 Expression at the Invasive Tumor Front as a Prognostic Indicator in OSCC. [PDF]

Int J Mol Sci
Nieberle F, Spoerl S, Strotzer Q, Hartmann R, Erber R, Spoerl S, Schuderer JG, Himmelstoß K, Meier J, Ettl T, Reichert TE, Taxis J.   +11 more
europepmc   +1 more source

Immune hub genes and a proof-of-concept prognostic signature in EBV-associated gastric carcinoma. [PDF]

iScience
Huo RZ, Yang RH, Zeng RH, Fang ZC, Li B, Pan YH, Guo JR, Guan YX, Shao CK, Yu DN, Liang SH, Shao YT, Du Y, Chen JN.   +13 more
europepmc   +1 more source

Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial. [PDF]

Nat Commun
Zheng X, Liu H, Shi L, Zeng Z, Zhang X, Luo S, Cai Y, Li Z, Liu Z, Hou Y, Yang Z, He X, Ke J, Huang L, Luo Y, Kang L.   +15 more
europepmc   +1 more source

Immunotherapy for microsatellite-stable colorectal cancer: overcoming resistance and exploring novel therapeutic strategies. [PDF]

Ann Coloproctol
Kim SY.
europepmc   +1 more source

Toward a more robust predictive model in esophageal cancer: methodological considerations for the combined use of immunoscore and pan-immune inflammation value. [PDF]

Int J Surg
Zhu C, Wang J, Kang Y.
europepmc   +1 more source